Clinical Trials Logo

Seasonal Allergies clinical trials

View clinical trials related to Seasonal Allergies.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02578914 Completed - Clinical trials for Allergic Conjunctivitis

A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis

Start date: August 2015
Phase: Phase 2
Study type: Interventional

This is a randomized, parallel, single center, double masked, vehicle controlled study. The purpose of this study is to determine the activity and safety of NS2 in patients with grass, tree or ragweed-pollen induced seasonal allergic conjunctivitis . Subjects will be randomized 1:1 to receive multiple doses of NS2 Ophthalmic Drops (0.5%) or NS2 Ophthalmic Drops Vehicle (0.0%). Free aldehydes are thought to be related to inflammatory conditions such as allergic conjunctivitis. NS2, a small molecule aldehyde trap, is being evaluated to determine whether it may decrease inflammation by lowering aldehyde levels.

NCT ID: NCT00533208 Completed - Seasonal Allergies Clinical Trials

MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED)

Start date: July 2003
Phase: Phase 2
Study type: Interventional

To assess the efficacy of MK0524 on seasonal allergies.